Groups representing health care providers, public health professionals, scientists, patients, and the biotech and diagnostics industries came together last month in support of addressing the mounting threat of antibiotic resistance.
Clostridioides difficile, formerly known as Clostridium difficile, causes almost half a million infections in the U.S. yearly. It's time more people knew about the bacterial infection—and why antibiotics are so vital in treating it.
Antibiotics are fundamental to modern medicine, essential for treating everything from routine skin infections to strep throat, and for protecting vulnerable patients receiving chemotherapy or being treated in intensive care units.
Pew's antibiotic resistance project is working to ensure both the prudent use of existing drugs and a robust pipeline of new drugs in order to meet current and future patient needs.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.